alexa Incompatible Blood Transfusion In Autoimmune Hemolytic Anemia In An Adult Asymptomatic Hepatitis B Carrier: A Case Report
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

7th World Hematologists Congress
May 08-09, 2017 Barcelona, Spain

Rizza T Antenor
Southern Philippines Medical Center, Philippines
Posters & Accepted Abstracts: J Blood Disord Transfus
DOI: 10.4172/2155-9864-C1-023
Autoimmune hemolytic anemia is an uncommon condition caused by antibodies directed against red blood cells causing their premature destruction. Clinical manifestations include anemia, jaundice, splenomegaly, reticulocytosis, elevated serum bilirubin, and positive direct antiglobulin test. Autoimmune hemolytic anemia (AIHA) can either be idiopathic or secondary to an underlying disease process. Infection accounts for 5% of cases of secondary AIHA. AIHA in asymptomatic hepatitis B carrier is rare with only two cases reported worldwide. Both cases were pediatric patients. We presented with a case of a 27 year old male who came in due to anemia. Patient presented with the classic manifestation of AIHA and workup for underlying cause revealed a carrier state of hepatitis B infection. Patient was unresponsive to steroid and was persistently dyspneic and tachycardic. Blood transfusion with an incompatible blood was done which resolved the patient’s symptoms. Steroid remains to be the mainstay of treatment for AIHA. However, blood transfusion may be beneficial to symptomatic patients at risk for complications of severe anemia. Although sustained remission is typical in inactive carriers of hepatitis B, reactivation remains a possibility, hence, patient education and good follow up is essential.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version